Study of Beta-Blocker Therapy, Heart Rate Changes, and Blood Biomarkers After Myocardial Infarction

A Prospective Observational Study of the Association Between Sympathetic Nervous System- and beta-Adrenergic Receptor-Related Biomarkers, Heart Rate Trajectory, and Left Ventricular Remodeling Indices, Focusing on Beta-Blocker Therapy in Patients After Acute Myocardial Infarction - Post-AMI Heart Rate and Left Ventricular Remodeling Indices Study Focusing on Beta-Blocker Therapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061731

Enrollment

100

Registered

2026-06-01

Start date

2026-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are 18 years of age or older at the time of consent. Patients diagnosed Acute myocardial infarction introduced to beta-blocker. Patients who have been fully informed of the study and who have given written consent of their own free will.

Exclusion criteria

Exclusion criteria: Patients with significantly poor medication adherence Patients with advanced cancer Patients with a history of autoimmune disease. Patients deemed inappropriate by the attending physician, etc.

Design outcomes

Primary

Measure	Time frame
Heart rate trajectory, changes in NT-proBNP levels, and changes in left ventricular function and left ventricular remodeling indices.	—

Countries

Japan

Contacts

Public ContactMasaki Kawata

Hamamatsu University School of Medicine Hospital Pharmacy

k.masaki@hama-med.ac.jp053-435-2711

Outcome results